What is the share price of Bliss GVS Pharma Ltd (BLISSGVS) today?
The share price of BLISSGVS as on 5th December 2025 is ₹167.41. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Bliss GVS Pharma Ltd (BLISSGVS) share?
The past returns of Bliss GVS Pharma Ltd (BLISSGVS) share are- Past 1 week: -7.76%
- Past 1 month: -0.76%
- Past 3 months: 6.82%
- Past 6 months: 25.50%
- Past 1 year: 3.69%
- Past 3 years: 126.57%
- Past 5 years: -2.81%
What are the peers or stocks similar to Bliss GVS Pharma Ltd (BLISSGVS)?
The peers or stocks similar to Bliss GVS Pharma Ltd (BLISSGVS) include:What is the dividend yield % of Bliss GVS Pharma Ltd (BLISSGVS) share?
The current dividend yield of Bliss GVS Pharma Ltd (BLISSGVS) is 0.30.What is the market cap of Bliss GVS Pharma Ltd (BLISSGVS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bliss GVS Pharma Ltd (BLISSGVS) is ₹1764.19 Cr as of 5th December 2025.What is the 52 week high and low of Bliss GVS Pharma Ltd (BLISSGVS) share?
The 52-week high of Bliss GVS Pharma Ltd (BLISSGVS) is ₹190.97 and the 52-week low is ₹108.12.What is the PE and PB ratio of Bliss GVS Pharma Ltd (BLISSGVS) stock?
The P/E (price-to-earnings) ratio of Bliss GVS Pharma Ltd (BLISSGVS) is 20.93. The P/B (price-to-book) ratio is 1.62.Which sector does Bliss GVS Pharma Ltd (BLISSGVS) belong to?
Bliss GVS Pharma Ltd (BLISSGVS) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Bliss GVS Pharma Ltd (BLISSGVS) shares?
You can directly buy Bliss GVS Pharma Ltd (BLISSGVS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Bliss GVS Pharma Ltd
BLISSGVS Share Price
BLISSGVS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
BLISSGVS Performance & Key Metrics
BLISSGVS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 16.09 | 1.62 | 0.30% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
BLISSGVS Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
BLISSGVS Company Profile
Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations.
BLISSGVS Forecast
BLISSGVS Forecasts
BLISSGVS
BLISSGVS
Income
Balance Sheet
Cash Flow
BLISSGVS Income Statement
BLISSGVS Income Statement
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 810.94 | 841.18 | 936.20 | 728.50 | 597.43 | 778.94 | 769.38 | 798.98 | 846.22 | 943.23 | ||||||||||
| Raw Materials | 368.69 | 391.70 | 618.79 | 435.67 | 341.59 | 420.18 | 374.38 | 390.46 | 421.80 | 736.31 | ||||||||||
| Power & Fuel Cost | 5.58 | 5.49 | 4.76 | 5.88 | 8.14 | 8.25 | 7.13 | 10.43 | 11.33 | |||||||||||
| Employee Cost | 61.35 | 69.23 | 42.32 | 53.69 | 68.09 | 76.15 | 86.17 | 95.58 | 112.05 | |||||||||||
| Selling & Administrative Expenses | 117.90 | 87.57 | 49.96 | 45.30 | 44.91 | 80.65 | 80.45 | 85.89 | 92.31 | |||||||||||
| Operating & Other expenses | 42.19 | 97.72 | 25.10 | 38.83 | 7.82 | 117.48 | 86.13 | 66.45 | 45.55 | |||||||||||
| EBITDA | 215.23 | 189.47 | 195.27 | 149.13 | 126.88 | 76.23 | 135.12 | 150.17 | 163.18 | 206.92 | ||||||||||
| Depreciation/Amortization | 20.14 | 21.38 | 8.94 | 12.59 | 17.23 | 17.33 | 18.67 | 26.38 | 29.42 | 32.05 | ||||||||||
| PBIT | 195.09 | 168.09 | 186.33 | 136.54 | 109.65 | 58.90 | 116.45 | 123.79 | 133.76 | 174.87 | ||||||||||
| Interest & Other Items | 19.69 | 22.80 | 4.41 | 7.57 | 5.51 | 4.74 | 10.36 | 6.91 | 8.12 | 11.27 | ||||||||||
| PBT | 175.40 | 145.29 | 181.92 | 128.97 | 104.14 | 54.16 | 106.09 | 116.88 | 125.64 | 163.60 | ||||||||||
| Taxes & Other Items | 93.36 | 86.51 | 58.19 | 31.71 | 35.63 | 39.13 | 35.22 | 41.41 | 41.35 | 53.96 | ||||||||||
| Net Income | 82.04 | 58.78 | 123.73 | 97.26 | 68.51 | 15.03 | 70.87 | 75.47 | 84.29 | 109.64 | ||||||||||
| EPS | 7.95 | 5.70 | 12.00 | 9.43 | 6.64 | 1.45 | 6.82 | 7.23 | 8.03 | 10.41 | ||||||||||
| DPS | 0.60 | 1.00 | 1.00 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | ||||||||||
| Payout ratio | 0.08 | 0.18 | 0.08 | 0.05 | 0.08 | 0.34 | 0.07 | 0.07 | 0.06 | 0.05 |
BLISSGVS Company Updates
BLISSGVS Stock Peers
BLISSGVS Past Performance & Peer Comparison
BLISSGVS Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Bliss GVS Pharma Ltd | 20.93 | 1.62 | 0.30% |
| Sun Pharmaceutical Industries Ltd | 39.92 | 6.02 | 0.88% |
| Torrent Pharmaceuticals Ltd | 67.21 | 16.92 | 0.84% |
| Cipla Ltd | 23.30 | 3.93 | 1.05% |
BLISSGVS Stock Price Comparison
Compare BLISSGVS with any stock or ETFBLISSGVS Holdings
BLISSGVS Shareholdings
BLISSGVS Promoter Holdings Trend
BLISSGVS Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
BLISSGVS Institutional Holdings Trend
BLISSGVS Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
BLISSGVS Shareholding Pattern
BLISSGVS Shareholding Pattern
BLISSGVS Shareholding History
BLISSGVS Shareholding History
Mutual Funds Invested in BLISSGVS
Mutual Funds Invested in BLISSGVS
No mutual funds holding trends are available
Top 1 Mutual Funds holding Bliss GVS Pharma Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0008% | Percentage of the fund’s portfolio invested in the stock 0.08% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 89/124 (-6) |
Compare 3-month MF holding change on Screener
smallcases containing BLISSGVS stock
smallcases containing BLISSGVS stock
Looks like this stock is not in any smallcase yet.
BLISSGVS Events
BLISSGVS Events
BLISSGVS Dividend Trend
BLISSGVS has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.30%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.99 every year
Dividends
Corp. Actions
Announcements
Legal Orders
BLISSGVS Dividend Trend
BLISSGVS has increased or maintained dividend levels over the last 5 years
Current dividend yield is 0.30%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹2.99 every year
BLISSGVS Upcoming Dividends
BLISSGVS Upcoming Dividends
No upcoming dividends are available
BLISSGVS Past Dividends
BLISSGVS Past Dividends
Cash Dividend
Ex DateEx DateJul 24, 2025
Dividend/Share
₹0.50
Ex DateEx Date
Jul 24, 2025
Cash Dividend
Ex DateEx DateJul 18, 2024
Dividend/Share
₹0.50
Ex DateEx Date
Jul 18, 2024
Cash Dividend
Ex DateEx DateJul 12, 2023
Dividend/Share
₹0.50
Ex DateEx Date
Jul 12, 2023
Cash Dividend
Ex DateEx DateJun 20, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Jun 20, 2022
Cash Dividend
Ex DateEx DateSep 13, 2021
Dividend/Share
₹0.50
Ex DateEx Date
Sep 13, 2021
BLISSGVS Stock News & Opinions
BLISSGVS Stock News & Opinions
Saatvik Green Energy Ltd, R S Software (India) Ltd, Vivid Mercantile Ltd and G K P Printing & Packaging Ltd are among the other losers in the BSE's 'B' group today, 07 November 2025.Bliss GVS Pharma Ltd tumbled 14.42% to Rs 130 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 3.34 lakh shares were traded on the counter so far as against the average daily volumes of 36100 shares in the past one month.Saatvik Green Energy Ltd lost 10.00% to Rs 484.35. The stock was the second biggest loser in 'B' group.On the BSE, 1.11 lakh shares were traded on the counter so far as against the average daily volumes of 91503 shares in the past one month.R S Software (India) Ltd crashed 9.98% to Rs 57.52. The stock was the third biggest loser in 'B' group.On the BSE, 49149 shares were traded on the counter so far as against the average daily volumes of 7695 shares in the past one month.Vivid Mercantile Ltd dropped 8.86% to Rs 4.22. The stock was the fourth biggest loser in 'B' group.On the BSE, 3.1 lakh shares were traded on the counter so far as against the average daily volumes of 3.82 lakh shares in the past one month.G K P Printing & Packaging Ltd fell 8.31% to Rs 7.61. The stock was the fifth biggest loser in 'B' group.On the BSE, 35399 shares were traded on the counter so far as against the average daily volumes of 74853 shares in the past one month.Powered by Capital Market - Live
Net profit of Bliss GVS Pharma rose 12.32% to Rs 27.25 crore in the quarter ended September 2025 as against Rs 24.26 crore during the previous quarter ended September 2024. Sales rose 12.27% to Rs 244.40 crore in the quarter ended September 2025 as against Rs 217.68 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales244.40217.68 12 OPM %13.0019.05 - PBDT48.8942.69 15 PBT40.6335.71 14 NP27.2524.26 12 Powered by Capital Market - Live
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live
Foseco India Ltd, Saurashtra Cement Ltd, Omax Autos Ltd and Manaksia Aluminium Company Ltd are among the other gainers in the BSE's 'B' group today, 30 July 2025.Bliss GVS Pharma Ltd spiked 16.86% to Rs 181.9 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 8.93 lakh shares were traded on the counter so far as against the average daily volumes of 30153 shares in the past one month. Foseco India Ltd surged 15.34% to Rs 5586.2. The stock was the second biggest gainer in 'B' group. On the BSE, 3871 shares were traded on the counter so far as against the average daily volumes of 186 shares in the past one month. Saurashtra Cement Ltd soared 13.27% to Rs 122. The stock was the third biggest gainer in 'B' group. On the BSE, 1.8 lakh shares were traded on the counter so far as against the average daily volumes of 69844 shares in the past one month. Omax Autos Ltd added 13.13% to Rs 145.81. The stock was the fourth biggest gainer in 'B' group. On the BSE, 98312 shares were traded on the counter so far as against the average daily volumes of 65323 shares in the past one month. Manaksia Aluminium Company Ltd rose 12.62% to Rs 32.66. The stock was the fifth biggest gainer in 'B' group. On the BSE, 82828 shares were traded on the counter so far as against the average daily volumes of 57186 shares in the past one month. Powered by Capital Market - Live
Net profit of Bliss GVS Pharma rose 107.92% to Rs 43.04 crore in the quarter ended June 2025 as against Rs 20.70 crore during the previous quarter ended June 2024. Sales rose 12.98% to Rs 207.47 crore in the quarter ended June 2025 as against Rs 183.64 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales207.47183.64 13 OPM %19.9218.69 - PBDT71.3136.92 93 PBT63.1130.07 110 NP43.0420.70 108 Powered by Capital Market - Live
Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 29 July 2025.Powered by Capital Market - Live
Northern ARC Capital Ltd, Apollo Micro Systems Ltd, IRM Energy Ltd and Malu Paper Mills Ltd are among the other gainers in the BSE's 'B' group today, 23 June 2025.Bliss GVS Pharma Ltd soared 9.58% to Rs 151.5 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.18 lakh shares were traded on the counter so far as against the average daily volumes of 68368 shares in the past one month. Northern ARC Capital Ltd spiked 9.58% to Rs 228.15. The stock was the second biggest gainer in 'B' group. On the BSE, 14.3 lakh shares were traded on the counter so far as against the average daily volumes of 5.2 lakh shares in the past one month. Apollo Micro Systems Ltd surged 9.00% to Rs 212.55. The stock was the third biggest gainer in 'B' group. On the BSE, 16.72 lakh shares were traded on the counter so far as against the average daily volumes of 11.4 lakh shares in the past one month. IRM Energy Ltd spurt 8.85% to Rs 311.9. The stock was the fourth biggest gainer in 'B' group. On the BSE, 19887 shares were traded on the counter so far as against the average daily volumes of 5288 shares in the past one month. Malu Paper Mills Ltd gained 8.44% to Rs 41.65. The stock was the fifth biggest gainer in 'B' group. On the BSE, 4676 shares were traded on the counter so far as against the average daily volumes of 3845 shares in the past one month. Powered by Capital Market - Live
Bliss GVS Pharma has allotted 75,250 equity shares under ESOP on 06 June 2025. Consequently, the paid up equity share capital has increased to 10,54,45,522 equity shares of Re. 1/- each aggregating Rs. 10,54,45,522 /. Powered by Capital Market - Live
Bliss GVS Pharma announced that the 40th Annual General Meeting(AGM) of the company will be held on 31 July 2025.Powered by Capital Market - Live
Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 12 May 2025, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 3.04%, vs industry avg of 10.03%
Over the last 5 years, market share decreased from 0.29% to 0.2%
Over the last 5 years, net income has grown at a yearly rate of -2.82%, vs industry avg of 20.02%